Skip to main content
. 2016 Jul 13;7(32):51713–51719. doi: 10.18632/oncotarget.10563

Figure 5.

Figure 5

(A) the proportion of apoptotic cells following TUG1 siRNA treatment was increased in LoVo cells; (B) the proportion of apoptotic cells following TUG1 siRNA treatment was increased in SW480 cells.

HHS Vulnerability Disclosure